rs10411676

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.101-6084T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.395 in 151,640 control chromosomes in the GnomAD database, including 12,064 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12064 hom., cov: 28)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.170

Publications

6 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.101-6084T>C intron_variant Intron 1 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.101-6084T>C intron_variant Intron 1 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.101-6084T>C intron_variant Intron 1 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.101-6084T>C intron_variant Intron 1 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.101-6084T>C intron_variant Intron 1 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.101-6084T>C intron_variant Intron 1 of 20 1 ENSP00000342838.4 P06213-2
INSRENST00000598216.1 linkn.76-6084T>C intron_variant Intron 1 of 9 1

Frequencies

GnomAD3 genomes
AF:
0.395
AC:
59797
AN:
151522
Hom.:
12047
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.382
Gnomad AMI
AF:
0.321
Gnomad AMR
AF:
0.425
Gnomad ASJ
AF:
0.458
Gnomad EAS
AF:
0.139
Gnomad SAS
AF:
0.274
Gnomad FIN
AF:
0.357
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.376
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.395
AC:
59837
AN:
151640
Hom.:
12064
Cov.:
28
AF XY:
0.391
AC XY:
28932
AN XY:
74072
show subpopulations
African (AFR)
AF:
0.382
AC:
15792
AN:
41368
American (AMR)
AF:
0.425
AC:
6465
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.458
AC:
1590
AN:
3470
East Asian (EAS)
AF:
0.139
AC:
709
AN:
5106
South Asian (SAS)
AF:
0.274
AC:
1315
AN:
4798
European-Finnish (FIN)
AF:
0.357
AC:
3758
AN:
10514
Middle Eastern (MID)
AF:
0.421
AC:
123
AN:
292
European-Non Finnish (NFE)
AF:
0.427
AC:
29007
AN:
67870
Other (OTH)
AF:
0.372
AC:
785
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1796
3593
5389
7186
8982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.419
Hom.:
52256
Bravo
AF:
0.401
Asia WGS
AF:
0.236
AC:
823
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.12
DANN
Benign
0.31
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10411676; hg19: chr19-7273991; API